{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:36:37Z","timestamp":1790710597830,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.euroneuro.2012.06.001","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T19:00:37Z","timestamp":1340910037000},"page":"728-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor"],"prefix":"10.1016","volume":"23","author":[{"given":"Rui","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng-Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Gang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Quan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2012.06.001_bib1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.pbb.2008.02.014","article-title":"Role for serotonin in the antidepressant-like effects of a flavonoid extract of Xiaobuxin-Tang","volume":"89","author":"An","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I","article-title":"SSRIs versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability","volume":"7","author":"Anderson","year":"1998","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bmb\/57.1.161","article-title":"Meta-analytical studies on new antidepressants","volume":"57","author":"Anderson","year":"2001","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00213-005-0087-3","article-title":"Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties","volume":"182","author":"Artaiz","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib5","series-title":"Statistics in Biology","author":"Bliss","year":"1967"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00181937","article-title":"The effects of chronic antidepressant treatment in an animal model of anxiety","volume":"95","author":"Bodnoff","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.npp.1301410","article-title":"Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment","volume":"33","author":"Bondi","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0149-7634(94)00050-B","article-title":"Role of the serotonergic system in the forced swimming test","volume":"19","author":"Borsini","year":"1995","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib10","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.bmcl.2003.08.079","article-title":"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake","volume":"13","author":"Bymaster","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2174\/1381612053764805","article-title":"The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression","volume":"11","author":"Bymaster","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib13","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s11064-010-0245-9","article-title":"Na+, K+ ATPase activity is reduced in amygdala of rats with chronic stress-induced anxiety-like behavior","volume":"35","author":"Crema","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib16","first-page":"131","article-title":"Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study","volume":"90","author":"Danish University Antidepressant Group","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0165-0327(90)90081-I","article-title":"Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study","volume":"18","author":"Danish University Antidepressant Group","year":"1990","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib18","first-page":"1","article-title":"The history of Marsilid","volume":"19","author":"Davis","year":"1958","journal-title":"J. Clin. Exp. Psychopathol."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib19","first-page":"16","article-title":"Common pathways of depression and pain","volume":"65","author":"Delgado","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1345\/aph.1K114","article-title":"Antidepressant-induced liver injury","volume":"41","author":"DeSanty","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0006-2952(84)90305-8","article-title":"Mechanisms of toxic injury to isolated hepatocytes by 1-naphthol","volume":"33","author":"Doherty","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/07853890008995932","article-title":"Evidence-based data on pain relief with antidepressants","volume":"32","author":"Fishbain","year":"2000","journal-title":"Ann. Med."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.jcp.0000132448.65972.d9","article-title":"Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine","volume":"24","author":"Goldstein","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib25","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1471-4159.1986.tb00649.x","article-title":"Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex","volume":"46","author":"Janowsky","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0149-7634(81)90005-1","article-title":"Acute and chronic stress effects on open field activity in the rat: implications for a model of depression","volume":"5","author":"Katz","year":"1981","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib27","first-page":"267","article-title":"Clinical pharmacology of imipramine and related antidepressant compounds","volume":"3","author":"Klerman","year":"1967","journal-title":"Int. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0028-3908(03)00268-5","article-title":"Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats","volume":"45","author":"Koch","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1176\/ajp.115.5.459","article-title":"The treatment of depressive states with G 22355 (imipramine hydrochloride)","volume":"115","author":"Kuhn","year":"1958","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"Lucki","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nurt.2008.10.039","article-title":"Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs","volume":"6","author":"Millan","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)29416-7","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3565(24)29415-5","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbr.2006.07.029","article-title":"Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice","volume":"175","author":"Mineur","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archpsyc.1991.01810280019002","article-title":"A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression","volume":"48","author":"Nelson","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00004850-200206001-00002","article-title":"The neuropharmacology of serotonin and noradrenaline in depression","volume":"17","author":"Nutt","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s002130051156","article-title":"Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test","volume":"147","author":"Page","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(95)00697-4","article-title":"Pharmacological validation of the chronic mild stress model of depression","volume":"296","author":"Papp","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressive treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib42","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050638","article-title":"Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal modelsindicative of antidepressant activity","volume":"138","author":"Redrobe","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"R\u00e9n\u00e9ric","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib45","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1176\/appi.ps.52.11.1469","article-title":"Can recovery from depression be achieved?","volume":"52","author":"Shelton","year":"2001","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib46","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS. Spectr."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib47","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1097\/01.BRS.0000092372.73527.BA","article-title":"Systematic review of antidepressants in the treatment of chronic low back pain","volume":"28","author":"Staiger","year":"2003","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9","article-title":"Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis","volume":"6","author":"Steffens","year":"1997","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.brainresbull.2007.08.009","article-title":"Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice","volume":"75","author":"Tanaka","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors","volume":"178","author":"Thase","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib52","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/jcp.0b013e31815a4412","article-title":"Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder","volume":"27","author":"Thase","year":"2007","journal-title":"J. Clin. Psychopharm."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib53","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/157488608784529189","article-title":"Hepatic effects of duloxetine-I: non-clinical and clinical trial data","volume":"3","author":"Wernicke","year":"2008","journal-title":"Curr. Drug. Saf."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00187257","article-title":"Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant","volume":"93","author":"Willner","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2012.06.001_bib55","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-0348-8183-8_5","article-title":"Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?","volume":"58","author":"Wong","year":"2002","journal-title":"Prog. Drug. Res."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib57","first-page":"421","article-title":"Pharmacodynamic and toxicological evaluation of duloxetin","volume":"26","author":"Xue","year":"2010","journal-title":"Chin. Pharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2012.06.001_bib58","first-page":"869","article-title":"Design, synthesis and antidepressive activity of duloxetine derivatives","volume":"45","author":"Zhang","year":"2010","journal-title":"Yao Xue Xue Bao"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12001538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12001538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T21:45:34Z","timestamp":1743630334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12001538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0924977X12001538"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.06.001","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}